The use of tissue microarrays in oncology: from research to diagnostic application
Authors
R. Franco
Pathology Unit, Istituto Nazionale Tumori IRCCS – “Fondazione G. Pascale”, Napoli, Italy.
G. Scognamiglio
Pathology Unit, Istituto Nazionale Tumori IRCCS – “Fondazione G. Pascale”, Napoli, Italy.
Keywords:
diagnosis, oncology, tissue microarrays
Abstract
Tissue microarray (TMA) technology has been widely developed and utilized in recent years for all tissue-based oncology research, mainly to identify prognostic and predictive biomarkers in cancer research. Recently the use of TMA has been implemented in the clinical setting, in order to provide cancer-specific molecular data needed to define the correct therapeutic strategy. In this context, the definition of the receptor status of breast cancer seems to be the best example of application in clinical pathology laboratories. In this review, we analyze the fields of application of TMA technology in oncology.